VISION

Inspiring transformational change in the

field of oncology diagnostics

MISSION

To develop and deliver accurate, rapid, minimally

invasive oncology diagnostic products utilising our

patented MCM5 antibodies

Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.

ADXBLADDER

MCM5 ELISA KIT


MCM Technology

 


Latest News

Arquer Diagnostics @Arquer Diagnostics
June is #ProstateCancerMonth, and #Arquer are at the forefront of this battle. We're working with many great #urologists to improve the pathway of #prostate #cancer #diagnostics. https://t.co/aL5eSKZmkj

- 7 days ago

1
Arquer Diagnostics @Arquer Diagnostics
#Arquer are pleased to confirm that we're attending #BAUS2019 - the British Annual Urology Society Meeting in Glasgow, on Jun 24-26th, where we'll be presenting #ADXBLADDER and meeting #urologists to create new alliances. https://t.co/j6srTBuKI8

- 10 days ago

1 1
Arquer Diagnostics @Arquer Diagnostics
What a privilege to speak at the Women in #Biopharma #Leadership event on 15 May, together with Jenny Rossiter! A group of talented, motivated and experienced women working together to further excellence in Biopharma. Until next time! #Arquer #lifesciences #cancer #oncology https://t.co/uvrF6NJnRf

- 19 days ago

2
Arquer Diagnostics @Arquer Diagnostics
We are proud to support @WorldBladderCan in their mission to provide #bladdercancer information worldwide, and build #medical alliances to improve #cancerpatient outcomes. https://t.co/pwETni8AUQ #bladdercanceraware #Arquer #ArquerDiagnostics #worldbladdercancer https://t.co/Hoy8GDPJFe

- 31 days ago

2
Arquer Diagnostics @Arquer Diagnostics
The results of our #ADXBLADDER are consistently excellent, proving the robustness of our non-invasive #cancer #diagnostics technology. #Urologists can now use this urine-based test to benefit patients worldwide. Click, to change #bladdercancer history: https://t.co/TtyefjKLku https://t.co/H8dDKHJvW8

- 40 days ago

1 1